[HTML][HTML] Chronic myeloid leukemia: cytogenetics and molecular biology's part in the comprehension and management of the pathology and treatment evolution

S Benchikh, A Bousfiha, A El Hamouchi… - … Human Genetics, 2022 - Springer
Chronic myeloid leukemia is a clonal myeloproliferative disease whose origin involves
an alteration in the genome in the hematopoietic stem cell compartment. This change …

Cytogenetics of chronic myeloid leukemia (CML)

B Balk, A Fabarius, C Haferlach - Chronic Myeloid Leukemia, 2021 - Springer
… detected by classical cytogenetics, but only by FISH or molecular genetic methods. Huntly et
… , which can only be detected by FISH or molecular genetic techniques such as RT-PCR, are …

Chronic myeloid leukaemia

J Cortes, C Pavlovsky, S Saußele - The Lancet, 2021 - thelancet.com
Tyrosine-kinase inhibitors have changed the natural history of chronic myeloid leukaemia in
such a way that patients with adequate access to these agents, who are properly managed, …

Genetic landscape of chronic myeloid leukemia

Y Ochi - International Journal of Hematology, 2023 - Springer
Cytogenetic studies and recent genetic studies using next-generation sequencing (NGS) …
domain mutations, but also additional cytogenetic and genetic abnormalities in CML. Additional …

Molecular, cytogenetic, and hematological analysis of chronic myeloid leukemia patients and discovery of two novel translocations

M Asif, A Hussain, A Wali, N Ahmed, I Ali… - Analytical Cellular …, 2021 - Wiley Online Library
Chronic myeloid leukemia is a disease of hematopoietic stem cells. CML is a type of cancer
caused by the balanced translocations between the long arms of chromosomes 9 and 22, t(9;…

[HTML][HTML] Atypical chronic myeloid leukemia: where are we now?

E Crisà, M Nicolosi, V Ferri, C Favini… - … Journal of Molecular …, 2020 - mdpi.com
Atypical chronic myeloid leukemia, BCR-ABL1 negative (aCML) is a rare myelodysplastic … )
with a high rate of transformation to acute myeloid leukemia, and poor survival. Until now, the …

[HTML][HTML] Genetic biomarkers in chronic myeloid leukemia: what have we learned so far?

B Abdulmawjood, B Costa, C Roma-Rodrigues… - … journal of molecular …, 2021 - mdpi.com
Chronic Myeloid Leukemia (CML) is a rare malignant proliferative disease of the hematopoietic
system, whose molecular … The Ph chromosome originates an aberrant fusion gene with …

Chronic myeloid leukemia

LAM Ferreira - Rare Diseases, 2020 - books.google.com
Chronic myelogenous leukemia (CML) is a chronic clonal myeloproliferative disease …
This chapter will review CML from its discovery, molecular and epigenetic mechanisms of …

Chronic myelogenous leukemia

H Kantarjian, E Jabbour, S O'Brien - Molecular Hematology, 2024 - Wiley Online Library
Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm that arises from
a … 9 and 22, and constitutes the cytogenetic hallmark of CML. It can be detected in …

[HTML][HTML] Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review

MM Sampaio, MLC Santos, HS Marques… - World journal of …, 2021 - ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm and was the first …
The advances in cytogenetic and molecular assays are of great importance to the diagnosis, …